Ureteral stent encrustation: possibilities of drug prophylaxis
https://doi.org/10.51922/1818-426X.2026.1.5
Abstract
Ureteral stenting is most often performed for urinary stasis secondary to urolithiasis and acute obstructive pyelonephritis. Among stenting complications, the most clinically significant are urinary tract infection and stent encrustation. Preventive measures for ureteral stenting complications have not yet been developed. This article presents a literature review of promising medications that can be used to prevent urinary tract infection associated with ureteral stents and their encrustation.
About the Authors
A. A. Gavrusev
Belarusian State Medical University
Belarus
Belarus
Minsk
G. Chokheli
4th City Clinical Hospital named after N. E. Savchenko
Belarus
Belarus
Minsk
N. A. Efimchik
4th City Clinical Hospital named after N. E. Savchenko
Belarus
Belarus
Minsk
D. M. Nitkin
Belarusian State Medical University
Belarus
Belarus
Minsk
References
1. A randomized clinical trial evaluating the short term results of ureteral stent encrustation in urolithiasis patients undergoing ureteroscopy: micro computed tomography evaluation / T. Yoshida [et al.]. // Scientific Reports. – 2021. – Vol. 11. – Р. 10337. – doi: 10.1038/s41598-02189808-x.
2. Role of ureteral stent material and coating to prevent ureteral stent related issue: A systematic review and meta analysis. / I. I. Putrantyo [et al.]. // Archivio Italiano di Urologia e Andrologia. – 2024. – 96. – Vol. 1. – P. 12067. – doi: 10.4081/aiua.2024.12067.
3. Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin / J. Bouckaert [et al.] // Molecular Microbiology. – 2005. – Vol. 55, iss. 2. – P. 441–455. – doi: 10.1111/j.13652958.2004.04415.x.
4. D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis / S. M. Lenger [et al.] // Am J Obstet Gynecol. – 2020. – Vol. 223, iss. 2. – P. 265.e1–265.e13. – doi: 10.1016/j.ajog.2020.05.048.
5. A prospective randomized study to define the role of low dose continuous prophylactic antibiotics and antiadherence agents in altering the microbial colonization related to indwelling double-J stents / K. Madhavan [et al.] // Asian Journal of Urology. – 2021. – Vol. 8. – P. 269–274. – doi: 10.1016/j.ajur.2020.08.003.
6. Profilaktika razvitiya kateter-associirovannyh infekcij mochevydelitel’noj sistemy u pacientov v rannem posleoperacionnom periode / A. S. Al’-Shukri [et al.] // Urologiya. – 2023. – № 2. – S. 13–19. – doi: 10.18565/urology.2023. 2.13-19.
7. Reduction of ureteral stent encrustation by modulating the urine pH and inhibiting the crystal film with a new oral composition: a multicenter, placebo controlled, double blind, randomized clinical trial / C. Torrecilla [et al.] // BMC Urology. – 2020. – Vol. 20. – P. 65. – doi: 10.1186/s12894-020-00633-2.
8. Effect of phytate on crystallization on ureteral stents and bacterial attachment: an in vitro study. / P. Calvó [et al.] // Urolithiasis. – 2022. – Vol. 50. – P. 737–742. – doi: org/10.1007/s00240-022-01350-1.
9. Single-center, double-blind, randomized, placebocontrolled pilot study of Canoxidin® for prevention of catheter encrustation in patients with indwelling catheters / A. Borau [et al.] // Actas Urol Esp (Engl Ed). – 2024 – Vol. 48, iss. 9. – P. 658–664. – doi: 10.1016/j.acuroe.2024.06.004.
10. Obidnyak, V. M. Mochetochnikovye stenty: eksperimental’naya ocenka svojstv i novye podhody k profilaktike oslozhnenij: dis. … kand. med. nauk / V. M. Obidnyak [Electronic resource]. – Access of mode: https://disser.spbu.ru/files/2025/disser_obidnyak.pdf. – Access of date: 26.09.2025.
11. The Composition of Catheter Encrustations, including the Effects of Allopurinol Treatment / H. Hedelin [et al.] // British Journal of Urology. – 1984. – Vol. 56. – P. 250–254.
12. Does potassium citrate administration change the type and composition of encrusted material on Double J stent compared to primary stone? / A. Mohammadi [et al.] // International Urology and Nephrology. – 2021. – Vol. 53. – P. 1797–1803. – doi: 10.1007/s11255-021-02891-x.
13. Comparison of the effects of potassium citrate and hydrochlorothiazide on the ureteral stent encrustation in patients with long stent survival; a single-blinded clinical trial / S. Farshid [et al.] // J Renal Inj Prev. – 2022. – Р. e25804. – doi: 10.34172/jrip.2022.25804.
14. Does alkalinised urine reduce the rate of encrustation in patients with ureteric stents? A randomised controlled study / L. S. Ch’ng [et al.] // International Urology and Nephrology. – 2022. – Vol. 54. – P. 509–515. – doi: 10.1007/s11255-022-03105-8.
15. Osobennosti inkrustacii mochetochnikovyh stentov u pacientov s kal’cij-oksalatnymi i mochekislymi konkrementami / A. A. Pranovich [et al.] // Urologiya. – 2023. – № 2. – S. 26–31. – doi: 10.18565/urology.2023.2.26-31.
16. Mochekamennaya bolezn’: opyt primeneniya i effektivnost’ Kanefrona®N. / A. A. Gres’, V. I. Voshchula, I. L. Rybina [i soavt.] // Medicinskie novosti. – 2004. – № 8. – S. 89–93.
Review
For citations:
Gavrusev A.A., Chokheli G., Efimchik N.A., Nitkin D.M. Ureteral stent encrustation: possibilities of drug prophylaxis. Medical Journal. 2026;(1):5-10. (In Russ.) https://doi.org/10.51922/1818-426X.2026.1.5
Views:
117
JATS XML
Email this article 